UCB Inc. v. Ranbaxy Laboratories Ltd.

Application Number	Patent Number	External Links
-	USRE38551	Espacenet Google Patents

COMPLAINT FOR PATENT INFRINGEMENT filed against Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1326011.) - filed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation. (Attachments: # 1 Exhibit A & B, # 2 Civil Cover Sheet)(dmp, ) (Entered: 07/11/2013)

2013-07-10

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 07/11/2013)

2013-07-10

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/05/2013. Date of Expiration of Patent: 03/17/2022.Thirty Month Stay Deadline: 12/5/2015. (dmp, ) (Entered: 07/11/2013)

2013-07-10

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE38,551;. (dmp, ) (Entered: 07/11/2013)

2013-07-10

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH identifying Corporate Parent UCB S.A., Other Affiliate UCB Holdings Inc., Other Affiliate UCB Lux S.A., Other Affiliate Fipar US Inc., Other Affiliate Medeva Ltd. for UCB Inc.; Corporate Parent UCB GmbH, Other Affiliate UCB S.A., Other Affiliate UCB Finance N.V. for UCB Pharma GmbH. (dmp, ) (Entered: 07/11/2013)

2013-07-10

1

View

Summons Issued with Magistrate Consent Notice attached as to Ranbaxy Inc. on 7/11/2013; Ranbaxy Laboratories Ltd. on 7/11/2013; Ranbaxy Pharmaceuticals Inc. on 7/11/2013. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (dmp, )

2013-07-11

1

No Actions

REQUEST FOR WAIVER of Service sent to Ranbaxy Laboratories Ltd. on July 11, 2013 by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH. Waiver of Service due by 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

2013-07-12

1

View

WAIVER OF SERVICE returned executed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation: For Ranbaxy Laboratories Ltd. waiver sent on 7/11/2013, answer due 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

2013-07-12

1

View

REQUEST FOR WAIVER of Service sent to Ranbaxy Phamaceuticals, Inc. on July 11, 2013 by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH. Waiver of Service due by 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

2013-07-12

1

View

WAIVER OF SERVICE returned executed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation: For Ranbaxy Pharmaceuticals Inc. waiver sent on 7/11/2013, answer due 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

2013-07-12

1

View

REQUEST FOR WAIVER of Service sent to Ranbaxy Inc. on July 11, 2013 by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH. Waiver of Service due by 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

2013-07-12

1

View

WAIVER OF SERVICE returned executed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation: For Ranbaxy Inc. waiver sent on 7/11/2013, answer due 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

2013-07-12

1

View

Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:13-cv-01206-LPS through 1:13-cv-01220-LPS (rjb)

2013-07-17

1

No Actions

NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc. (Cottrell, Frederick) (Entered: 07/25/2013)

2013-07-25

1

View

MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman and Carol Pitzel Cruz - filed by Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc.. (Cottrell, Frederick) (Entered: 07/25/2013)

2013-07-25

1

View

NOTICE of Appearance by Travis Steven Hunter on behalf of Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc. (Hunter, Travis) (Entered: 07/25/2013)

2013-07-25

1

View

SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman and Carol Pitzel Cruz filed by Ranbaxy Inc., Ranbaxy Pharmaceuticals Inc., Ranbaxy Laboratories Ltd. Signed by Judge Leonard P. Stark on 7/29/13. (ntl)

2013-07-29

1

No Actions

Pro Hac Vice Attorney Carol M. Pitzel Cruz,William R. Zimmerman for Ranbaxy Laboratories Ltd. added for electronic noticing. (dmp, )

2013-08-01

1

No Actions

Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 5, 2013. Date of Expiration of Patent: March 17, 2022.Thirty Month Stay Deadline: 4/28/2016. (Noreika, Maryellen) (Entered: 08/02/2013)

2013-08-02

1

View

MOTION for Pro Hac Vice Appearance of Attorney Robert L. Baechtold, Scott K. Reed, Ha Kung Wong, Joshua I. Rothman, Fiona E. Darkin, Kimberley A. Gavin, Daniel J. Minion, John P. Dillon and Caitlin P. Hogan - filed by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH. (Tigan, Jeremy) (Entered: 08/13/2013)

2013-08-13

1

View

SO ORDERED, re 16 MOTION for Pro Hac Vice Appearance of Attorney Robert L. Baechtold, Scott K. Reed, Ha Kung Wong, Joshua I. Rothman, Fiona E. Darkin, Kimberley A. Gavin, Daniel J. Minion, John P. Dillon and Caitlin P. Hogan filed by Research Corporation Technologies Inc., UCB Pharma GmbH, UCB Inc., Harris FRC Corporation. Signed by Judge Leonard P. Stark on 8/14/13. (ntl)

2013-08-14

1

No Actions

ANSWER to 1 Complaint,, COUNTERCLAIM against All Plaintiffs by Ranbaxy Inc., Ranbaxy Pharmaceuticals Inc., Ranbaxy Laboratories Ltd..(Hunter, Travis) (Entered: 09/09/2013)

2013-09-09

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc. identifying Corporate Parent Ranbaxy Inc. for Ranbaxy Pharmaceuticals Inc. ; Corporate Parent Ranbaxy Holdings (UK) Limited, Corporate Parent Ranbaxy (Netherlands) B.V. for Ranbaxy Inc.; Corporate Parent Daiichi Sankyo Company Limited for Ranbaxy Laboratories Ltd... (Hunter, Travis) (Entered: 09/09/2013)

2013-09-09

1

View

ANSWER to 17 Answer to Complaint, Counterclaim by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH.(Noreika, Maryellen) (Entered: 09/30/2013)

2013-09-30

1

View

ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal to the Court no later than January 6, 2014. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, Forms). ORDERED by Judge Leonard P. Stark on 12/10/13. Associated Cases: 1:13-cv-01148-LPS et al. (ntl) (Entered: 12/10/2013)

2013-12-10

1

View

PROPOSED ORDER (Scheduling) by Harris FRC Corporation, UCB Inc., UCB Pharma GmbH. (Attachments: # 1 Letter to the Honorable Leonard P. Stark)(Noreika, Maryellen) (Entered: 01/06/2014)

2014-01-06

1

View

ORAL ORDER: IT IS HEREBY ORDERED that a Rule 16 scheduling teleconference has been scheduled for January 28, 2014 at 9:45 a.m. Plaintiffs' counsel shall initiate the teleconference call to 302-573-4571. No further submissions are needed. ORDERED by Judge Leonard P. Stark on 1/16/14. Associated Cases: 1:13-cv-01148-LPS et al. (ntl) (Entered: 01/16/2014)

2014-01-16

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 1/28/2014. (Court Reporter B. Gaffigan.) Associated Cases: 1:13-cv-01206-LPS et al.(ntl)

2014-01-28

1

No Actions

NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH.(Noreika, Maryellen) (Entered: 01/29/2014)

2014-01-29

1

View

PROPOSED ORDER Scheduling by Breckenridge Pharmaceutical Inc., Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH, Vennoot Pharmaceuticals LLC, Sandoz Inc., Accord Healthcare Inc., Intas Pharmaceuticals Ltd., Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc., Apotex Corp., Apotex Inc., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Glenmark Generics Inc. USA, Glenmark Generics Ltd., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Alembic Limited, Alembic Pharmaceuticals Ltd., Hetero Labs Limited, Hetero USA Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Watson Laboratories Inc. - Florida, Watson Pharma Inc.. (Attachments: # 1 Letter)(Noreika, Maryellen) (Entered: 01/31/2014)

2014-01-31

1

View

Official Transcript of Telephone Conference on January 28, 2014 before Judge Leonard P. Stark. Court Reporter Brian P. Gaffigan, Telephone (302) 573-6360 Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/28/2014. Redacted Transcript Deadline set for 3/10/2014. Release of Transcript Restriction set for 5/8/2014. (bpg) (Entered: 02/07/2014)

2014-02-07

1

View

SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are consolidated for all purposes and all papers shall be filed in the Lead Case Civil Action No. 13-1206-LPS. Discovery due by 1/15/2015. Status Report due by 9/29/2014. Claim Construction Opening Brief due by 10/28/2014. Claim Construction Answering Brief due by 11/24/2014. A Markman Hearing is set for 12/15/2014 at 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. A Pretrial Conference is set for 10/22/2015 at 10:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 10/12/2015. A 5-day Bench Trial is set for 11/9/2015 at 09:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 2/7/14. (Attachments: # 1 Form of Pretrial Order) Associated Cases: 1:13-cv-01206-LPS et al. (ntl) (Entered: 02/10/2014)

2014-02-10

1

View

CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Associated Cases: 1:13-cv-01206-LPS et al.(dlk)

2014-02-10

1

No Actions

Case associated with lead case: Create association to 1:13-cv-01206-LPS. (ntl)

2014-02-12

1

No Actions

NOTICE OF SERVICE of Defendants Ranbaxy Laboratories, Ltd., Ranbaxy Pharmaceuticals Inc.s and Ranbaxy Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc..(Hunter, Travis) (Entered: 02/18/2014)

2014-02-18

1

View

ORAL ORDER: In light of the District Court's mediation referral in this case, and the number of parties involved in this matter and related cases, the Court orders as follows: Plaintiffs' counsel shall contact counsel for each defendant to discuss whether both sides believe that the Court's assistance with settlement discussions would be helpful at some point in the case. If both plaintiffs and an individual defendant believe that the case has reached a stage whereby the Court's assistance is needed with regard to settlement, plaintiff's counsel shall contact the Court to schedule an ADR Teleconference for plaintiffs and that individual defendant. Ordered by Judge Christopher J. Burke on 3/10/2014. Associated Cases: 1:13-cv-01206-LPS et al.(dlk)

2014-03-10

1

No Actions

STIPULATION OF DISMISSAL OF DEFENDANTS (filed in lead case no. 13-1206-LPS), ***Civil Case Terminated. (ntl) (Entered: 03/18/2014)

2014-03-18

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 38,551. (ntl) (Entered: 03/18/2014)

2014-03-18

1

View

ORAL ORDER: IT IS HEREBY ORDERED that the Pretrial Conference is hereby re-scheduled for October 23, 2015 beginning at 9:00 a.m. ORDERED by Judge Leonard P. Stark on 6/23/14. Associated Cases: 1:13-cv-01206-LPS et al. (ntl) (Entered: 06/23/2014)

2014-06-23

1

View

Overview

Parties

Defendant

Ranbaxy Inc. Follow

Represented By

Ranbaxy Pharmaceuticals Inc. Follow

Represented By

Ranbaxy Laboratories Ltd. Follow

Represented By

Plaintiff

Harris FRC Corporation Follow

Represented By

Research Corporation Technologies Inc. Follow

Represented By

UCB Pharma GmbH Follow

Represented By

UCB Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 07/11/2013)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/05/2013. Date of Expiration of Patent: 03/17/2022.Thirty Month Stay Deadline: 12/5/2015. (dmp, ) (Entered: 07/11/2013)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE38,551;. (dmp, ) (Entered: 07/11/2013)

REQUEST FOR WAIVER of Service sent to Ranbaxy Laboratories Ltd. on July 11, 2013 by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH. Waiver of Service due by 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

WAIVER OF SERVICE returned executed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation: For Ranbaxy Laboratories Ltd. waiver sent on 7/11/2013, answer due 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

REQUEST FOR WAIVER of Service sent to Ranbaxy Phamaceuticals, Inc. on July 11, 2013 by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH. Waiver of Service due by 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

WAIVER OF SERVICE returned executed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation: For Ranbaxy Pharmaceuticals Inc. waiver sent on 7/11/2013, answer due 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

REQUEST FOR WAIVER of Service sent to Ranbaxy Inc. on July 11, 2013 by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH. Waiver of Service due by 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

WAIVER OF SERVICE returned executed by UCB Pharma GmbH, UCB Inc., Research Corporation Technologies Inc., Harris FRC Corporation: For Ranbaxy Inc. waiver sent on 7/11/2013, answer due 9/9/2013. (Noreika, Maryellen) (Entered: 07/12/2013)

Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:13-cv-01206-LPS through 1:13-cv-01220-LPS (rjb)

NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc. (Cottrell, Frederick) (Entered: 07/25/2013)

MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman and Carol Pitzel Cruz - filed by Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc.. (Cottrell, Frederick) (Entered: 07/25/2013)

NOTICE of Appearance by Travis Steven Hunter on behalf of Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc. (Hunter, Travis) (Entered: 07/25/2013)

SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman and Carol Pitzel Cruz filed by Ranbaxy Inc., Ranbaxy Pharmaceuticals Inc., Ranbaxy Laboratories Ltd. Signed by Judge Leonard P. Stark on 7/29/13. (ntl)

Pro Hac Vice Attorney Carol M. Pitzel Cruz,William R. Zimmerman for Ranbaxy Laboratories Ltd. added for electronic noticing. (dmp, )

Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 5, 2013. Date of Expiration of Patent: March 17, 2022.Thirty Month Stay Deadline: 4/28/2016. (Noreika, Maryellen) (Entered: 08/02/2013)

ANSWER to 1 Complaint,, COUNTERCLAIM against All Plaintiffs by Ranbaxy Inc., Ranbaxy Pharmaceuticals Inc., Ranbaxy Laboratories Ltd..(Hunter, Travis) (Entered: 09/09/2013)

ANSWER to 17 Answer to Complaint, Counterclaim by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH.(Noreika, Maryellen) (Entered: 09/30/2013)

PROPOSED ORDER (Scheduling) by Harris FRC Corporation, UCB Inc., UCB Pharma GmbH. (Attachments: # 1 Letter to the Honorable Leonard P. Stark)(Noreika, Maryellen) (Entered: 01/06/2014)

Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 1/28/2014. (Court Reporter B. Gaffigan.) Associated Cases: 1:13-cv-01206-LPS et al.(ntl)

NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Harris FRC Corporation, Research Corporation Technologies Inc., UCB Inc., UCB Pharma GmbH.(Noreika, Maryellen) (Entered: 01/29/2014)

CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Associated Cases: 1:13-cv-01206-LPS et al.(dlk)

Case associated with lead case: Create association to 1:13-cv-01206-LPS. (ntl)

NOTICE OF SERVICE of Defendants Ranbaxy Laboratories, Ltd., Ranbaxy Pharmaceuticals Inc.s and Ranbaxy Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc..(Hunter, Travis) (Entered: 02/18/2014)

STIPULATION OF DISMISSAL OF DEFENDANTS (filed in lead case no. 13-1206-LPS), ***Civil Case Terminated. (ntl) (Entered: 03/18/2014)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 38,551. (ntl) (Entered: 03/18/2014)

ORAL ORDER: IT IS HEREBY ORDERED that the Pretrial Conference is hereby re-scheduled for October 23, 2015 beginning at 9:00 a.m. ORDERED by Judge Leonard P. Stark on 6/23/14. Associated Cases: 1:13-cv-01206-LPS et al. (ntl) (Entered: 06/23/2014)

Track Case Updates

Ranbaxy Inc.

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Laboratories Ltd.

Harris FRC Corporation

Research Corporation Technologies Inc.

UCB Pharma GmbH

UCB Inc.